Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

YOU WONT BELIEVE: 7 - You Need To See This

What's Going On With Summit Therapeutics Stock On Monday?

Summit Therapeutics Inc. (NASDAQ:SMMT) stock is trading lower on Monday. The company shared progress on its lead drug candidate and third-quarter financial results.

Benzinga

Merck's Keytruda Plus Chemo Regimen Shows Overall Survival Benefit In Recurrent Ovarian Cancer Patients

Merck Co. Inc. (NYSE:MRK) announced data from the Phase 3 KEYNOTE-B96 trial (ENGOT-ov65) of Keytruda (pembrolizumab) in combination with chemotherapy (paclitaxel) with or without Roche Holdings AG’s (OTC:RHHBY) Avastin (bevacizumab).

Benzinga

AstraZeneca/Daiichi Sankyo Partnered Breast Cancer Drug Shows Survival Benefit Over Chemotherapy

AstraZeneca Plc (NASDAQ:AZN) and Daiichi Sankyo on Monday released high-level results from the TROPION-Breast02 Phase 3 trial.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

‘I beat cancer – but a postcode lottery of fertility services nearly robbed me of hopes of becoming a mother’

Fertility preservation remains inconsistent with the NHS

The Independent UK

Coroner Exposes Mom For Contributing To Daughter’s Passing By Influencing Her To Refuse Chemo

“If coffee enemas were a sustainable treatment for cancer. We would’ve cured cancer years ago!”

Bored Panda

Kate Shemirani Daughter's Cause of Death: Why Is The Coroner Raising Serious Concerns?

Paloma Shemirani died after rejecting chemotherapy; the coroner cited her mother Kate Shemirani's influence as a major contributing factor.

International Business Times UK

‘My conspiracy theorist mother never told me my sister had died after refusing chemotherapy’

Paloma Shemirani died seven months after being diagnosed with cancer and pursuing ‘alternative treatment’ under her mother’s guidance

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Cambridge graduate who refused chemotherapy was ‘brainwashed’, says brother

Paloma Shemirani, 23, was ‘adversely influenced’ by her parents and others into not having chemotherapy after being diagnosed with cancer.

Evening Standard

UK woman who refused cancer drugs was influenced by mother, inquest finds

Paloma Shemirani, 23, died after refusing chemotherapy for non-Hodgkin lymphoma despite doctors’ concerns

The Guardian - UK

Woman who died after refusing chemotherapy ‘adversely influenced’ by mother

Paloma Shemirani, 23, collapsed on July 19 last year and was taken to Royal Sussex County Hospital where she died five days later.

Evening Standard

Conspiracy theorist mother ‘influenced’ daughter to reject chemotherapy after she was diagnosed with cancer

Kate Shemirani’s conduct of care towards daughter Paloma described as ‘incomprehensible’ by a coroner

The Independent UK

Halsey gives chemotherapy update on rare health disorder

Halsey has opened up about going through more chemotherapy for her rare health disorder.

The Independent UK

Halsey undergoing chemotherapy for rare T-cell disorder

The singer has been diagnosed with lupus and a rare T-cell lymphoproliferative disorder

The Independent UK

Trump's touting of an unproven autism drug surprised many, including the doctor who proposed it

A Trump administration decision to repurpose an old chemotherapy drug for autism has surprised many experts — including the physician who recently proposed the idea

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Mother diagnosed with incurable cancer after pain dismissed by doctors

Simone Williamson was diagnosed with myeloma after years of being ‘fobbed off’

International Business Times UK

Folinic Acid Secrets: Why Dr. Oz and iHerb Are Popularizing Leucovorin for Autism After Chemotherapy Success

Folinic acid gains attention as Dr. Oz and iHerb spotlight leucovorin's potential in autism after decades of chemotherapy use.

The Independent UK

‘I thought I had injured my back – but it was incurable blood cancer’

More than 33,000 people in the UK are living with myeloma, a type of incurable blood cancer that causes bone pain

The Independent UK

Dad diagnosed with stage 4 cancer after wife’s death from the illness

Paul Garratt lost his wife of 10 years to breast cancer in 2015 at the age of 31

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Regeneron's Libtayo Combo Achieves Nearly Double Survival Rate In Advanced Lung Cancer Compared To Chemotherapy

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on Tuesday announced five-year follow-up results on overall survival (OS) from the Phase 3 EMPOWER-Lung 3 trial of Libtayo (cemiplimab) plus platinum-based chemotherapy versus chemotherapy alone as a first-line treatment for adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) with no EGFR, ALK,…

Benzinga

BioNTech, Bristol Myers Squibb Show Tumor Shrinkage In Lung Cancer Immunotherapy

BioNTech SE (NASDAQ:BNTX) and Bristol Myers Squibb Co (NYSE:BMY) shared interim Phase 2 data on pumitamig (BNT327/BMS986545) plus chemotherapy in patients with untreated extensive-stage small cell lung cancer (ES-SCLC).

Benzinga

AstraZeneca Lung Cancer Combo Extends Patient Survival By Years In Key Study

On Sunday, AstraZeneca Plc (AZN) released results from the final overall survival (OS) analysis of the FLAURA2 Phase 3 trial in previously untreated patients with locally advanced (Stage IIIB-IIIC) or metastatic (Stage IV) non-small cell lung cancer (NSCLC) whose tumors have EGFR exon 19 deletion or exon 21 L858R mutations.

Benzinga

Summit Therapeutics' Lung Cancer Drug Under Dark Clouds As Keytruda Challenger Shows Regional Data Differences

Summit Therapeutics Inc. (NASDAQ:SMMT), on Sunday, revealed the updated overall survival (OS) results from the global Phase 3 HARMONi trial of ivonescimab at the 2025 World Conference on Lung Cancer (WCLC).

Benzinga

BioNTech Advances On Positive Phase 3 Breast Cancer Drug Data

On Friday, BioNTech SE (NASDAQ:BNTX) and its partner Duality Biologics (Suzhou) Co., Ltd. released topline data from a Phase 3 trial in China evaluating trastuzumab pamirtecan (BNT323/DB-1303) versus trastuzumab emtansine (T-DM1) for HER2-positive unresectable or metastatic breast cancer patients who have previously received trastuzumab and a taxane-based chemotherapy.

Benzinga

Amgen Faces Setback As Final Data Weakens Case For Gastric Cancer Drug

On Wednesday, Amgen Inc. (NASDAQ:AMGN) and its partner Zai Lab (NASDAQ:ZLAB) said the final analysis of the Phase 3 FORTITUDE-101 trial evaluating bemarituzumab in combination with chemotherapy (mFOLFOX6) in first-line gastric cancer has been completed.

Evening Standard

Dermot Murnaghan ‘feeling pretty good’ after chemotherapy for stage four cancer

The TV presenter, who has been diagnosed with prostate cancer, said men should demand testing on the NHS.

1 … 6 7 8 9

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.